nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis
|
Maria, Alexandre T. J. |
|
2016 |
52 |
2 |
p. 234-259 |
artikel |
2 |
An Update on the Use of Immunomodulators in Primary Immunodeficiencies
|
Vignesh, Pandiarajan |
|
2016 |
52 |
2 |
p. 287-303 |
artikel |
3 |
Beyond Genetics: What Causes Type 1 Diabetes
|
Wang, Zhen |
|
2016 |
52 |
2 |
p. 273-286 |
artikel |
4 |
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases
|
Favoino, Elvira |
|
2016 |
52 |
2 |
p. 217-233 |
artikel |
5 |
Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases
|
Shu, Ye |
|
2016 |
52 |
2 |
p. 260-272 |
artikel |
6 |
Molecular and Immunological Basis of Tubulo-Interstitial Injury in Lupus Nephritis: a Comprehensive Review
|
Yung, Susan |
|
2016 |
52 |
2 |
p. 149-163 |
artikel |
7 |
Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review
|
Slobodin, Gleb |
|
2016 |
52 |
2 |
p. 194-201 |
artikel |
8 |
Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance
|
Ungerer, Martin |
|
2016 |
52 |
2 |
p. 182-193 |
artikel |
9 |
The Clinical Relevance of Anti-DFS70 Autoantibodies
|
Conrad, Karsten |
|
2016 |
52 |
2 |
p. 202-216 |
artikel |
10 |
The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus
|
Goropevšek, Aleš |
|
2016 |
52 |
2 |
p. 164-181 |
artikel |